Innovation Pharmaceuticals Inc (IPIX)

[3dtdman]

Thanks, Sunspotter. Here's an update on another one, which I first heard about from someone on this board. Don't remember who it was, sorry:
https://www.prnewswire.com/news-releases/kintor-pharmaceuticals-announces-successful-proxalutamide-covid-19-phase-iii-clinical-trial-initiation-and-patient-dosing-in-us-301276372.html

There are detractors and reasons to be skeptical about this drug:
https://www.reuters.com/world/china/chinese-firms-covid-19-drug-claims-draw-scientists-skepticism-2021-05-14/

https://www.reuters.com/business/healthcare-pharmaceuticals/man-behind-brazils-search-miracle-covid-19-cures-2021-05-14/


But if there's anything to the validity of using androgen receptors to tread COVID-19 there may be something to it:
https://blogs.sciencemag.org/pipeline/archives/2021/03/11/androgen-receptors-for-covid-19

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899267/

https://clinicaltrials.gov/ct2/history/NCT04853927?A=1&B=2&C=merged#StudyPageTop

The company Kintor Pharmaceutical trades on the Hong Kong stock exchange, stock code 9939:HK